Albert Sabin

Albert Bruce Sabin was born on August 26, 1906, in Białystok, a textile manufacturing city then inside the Russian Empire and today part of Poland. His parents, Jacob and Tillie Saperstein, were Jewish weavers raising their children amid the poverty and antisemitic violence that pressed on the region's Jewish communities in the years around the First World War ^[1].

In 1921 the family emigrated to the United States and settled in Paterson, New Jersey, where relatives worked in the silk mills. Fifteen-year-old Albert arrived speaking no English. He learned the language quickly enough to graduate from Paterson High School in 1923, and the family later anglicized their surname to Sabin. He became a naturalized American citizen in 1930 ^[1][2].

An uncle offered to pay for his education on the condition that he train as a dentist, so Sabin enrolled at New York University in a pre-dental program. The arrangement collapsed after he read Paul de Kruif's popular 1926 book Microbe Hunters and decided that infectious disease research, not dentistry, was his calling. His uncle withdrew the funding, and Sabin supported himself through odd jobs and scholarships while switching to medicine. He earned his M.D. from New York University in 1931 ^[2][3].

Sabin's medical training coincided with a frightening moment in New York. During the summer of 1931, while he interned at Bellevue Hospital, a polio epidemic swept the city, and the young physician began working on the virus almost immediately. Even as a student he had shown a knack for laboratory science, developing a rapid typing method for pneumococcus bacteria ^[2][3].

After a research year at the Lister Institute in London, Sabin joined the Rockefeller Institute for Medical Research in New York in 1935. There, with Peter Olitsky, he demonstrated in 1936 that poliovirus could be grown in cultured human nervous tissue. The result was a technical landmark, though it reinforced a misleading assumption: because the virus thrived in nerve cells, many researchers concluded it was purely a disease of the nervous system, a belief that delayed vaccine work for years ^[3][4].

In 1939 Sabin moved to the Children's Hospital Research Foundation at the University of Cincinnati, the institution where he would spend most of his career. His research there overturned the old model of polio. By studying tissue from fatal cases, he and his colleagues showed that poliovirus first multiplies in the digestive tract and only later invades the nervous system. That finding meant an oral vaccine acting in the gut was feasible, and it set the direction for everything Sabin did afterward ^[3][4].

The Second World War interrupted this program but broadened his reputation. Serving with the U.S. Army Epidemiological Board, Lieutenant Colonel Sabin investigated diseases threatening American troops in the Mediterranean and Pacific theaters. He helped identify the sandfly fever virus, studied dengue, and developed a vaccine against Japanese encephalitis that was given to tens of thousands of soldiers ^[1][4].

Any account of Albert Sabin achievements centers on the years after 1945, when he returned to Cincinnati determined to build a live vaccine. His strategy differed sharply from that of Jonas Salk, who was developing an injectable vaccine made from killed virus. Sabin believed only a living, weakened virus could reproduce natural infection closely enough to produce durable immunity, and that an oral dose would block the virus where it first takes hold, in the intestine ^[4][5].

Through the early 1950s he passed polioviruses repeatedly through monkey tissue, hunting for mutant strains that could still multiply in the gut but had lost the ability to attack nerve cells. Selecting safe versions of all three poliovirus types required testing on thousands of monkeys and chimpanzees. Sabin swallowed his own experimental strains, and members of his research team and prisoner volunteers at the Chillicothe federal reformatory in Ohio took part in early trials ^[4][5].

Salk's killed vaccine was licensed in 1955, and American health authorities saw little reason to test a rival product at home. Sabin found his proving ground abroad. Working with Soviet virologists Mikhail Chumakov and Anatoli Smorodintsev during a rare Cold War scientific collaboration, he arranged trials in the USSR that grew into mass campaigns. By 1960 roughly 100 million people in the Soviet Union, Eastern Europe, and Mexico had received the Sabin strains, and the data convinced regulators of their safety ^[5][6].

The United States licensed the oral vaccine in stages during 1961 and 1962. Cheap to produce, painless to give, and capable of interrupting transmission within communities, it largely displaced the Salk shot in American practice by the mid 1960s. Communities organized 'Sabin Oral Sundays,' lining up by the millions for a vaccine-soaked sugar cube. Sabin never patented the strains and gave them to the World Health Organization and to manufacturers without royalty, insisting the vaccine belonged to the world's children ^[5][6].

Sabin married Sylvia Tregillus in 1935, and the couple raised two daughters, Deborah and Amy, in Cincinnati. Sylvia died in 1966. A brief second marriage to Jane Warner ended in divorce, and in 1972 he married Heloisa Dunshee de Abranches, a Brazilian journalist who remained his partner until his death and later worked to preserve his legacy ^[1][2].

Colleagues knew Sabin as tireless, blunt, and combative in scientific argument. His decades-long rivalry with Jonas Salk was genuine and often sharp; Sabin publicly disparaged the killed vaccine's approach for years, and the two men never reconciled their differences. Yet even critics acknowledged his rigor, and his insistence on exhaustive animal and human testing shaped the safety standards of modern vaccine development ^[4][6].

His Jewish heritage and immigrant childhood stayed with him. He spoke often of medicine as a repayment of debts to the country that had taken his family in, and he channeled the fame the vaccine brought him into international health advocacy rather than personal fortune ^[2].

Sabin formally retired from the University of Cincinnati in 1971 as Distinguished Service Professor Emeritus, but retirement never took. From 1970 to 1972 he served as president of the Weizmann Institute of Science in Israel, resigning after heart surgery. He later held research posts at the Medical University of South Carolina and, from 1984, at the Fogarty International Center of the National Institutes of Health in Bethesda, Maryland ^[1][2].

His late research reached beyond polio. He spent years investigating possible viral causes of cancer, and in 1971 he made headlines with a claim linking herpes viruses to human cancers, later retracting his conclusions when he could not reproduce the evidence, a public correction that he treated as ordinary scientific honesty. He also worked on an aerosolized measles vaccine intended for developing countries ^[2][6].

Honors accumulated through these decades: the U.S. National Medal of Science in 1970, the Presidential Medal of Freedom from Ronald Reagan in 1986, election to the National Academy of Sciences, and dozens of honorary degrees from universities around the world. In 1980 he traveled to Brazil to help organize national immunization days, campaigns that became a model for polio programs elsewhere in Latin America ^[1][6].

Severe illness marked his final years. Paralysis caused by calcification in his cervical spine left him in intense pain in the early 1980s until surgery restored his mobility, an ordeal he said gave him new sympathy for polio's victims. Albert Sabin died of congestive heart failure on March 3, 1993, in Washington, D.C., at the age of 86. He was buried in Arlington National Cemetery ^[1][2].

The clearest measure of Sabin's impact is epidemiological. In the early 1950s the United States recorded tens of thousands of paralytic polio cases each year; by 1979 wild poliovirus transmission in the country had ended. When the World Health Assembly launched the Global Polio Eradication Initiative in 1988, the oral vaccine's low cost and ease of delivery made it the campaign's standard tool, and reported polio cases worldwide have since fallen by more than 99 percent ^[6][7].

Any fair set of Albert Sabin facts must include the complications. Because the vaccine uses living virus, it causes vaccine-associated paralysis in roughly one recipient per several hundred thousand first doses, and in rare circumstances the weakened strains can circulate and regain virulence. Wealthy countries, the United States among them, returned to improved killed-virus vaccines around 2000 once wild polio was gone from their territories. The endgame of eradication now involves managing the very strains Sabin created, a paradox he anticipated in his own late writings ^[6][7].

Institutions carry his name forward. The Sabin Vaccine Institute, founded in 1993 shortly after his death, promotes vaccine development and access in low-income countries, and his archived papers are held by the University of Cincinnati, which also named its Children's Hospital research building in his honor. For students first encountering an Albert Sabin biography, his refusal to profit from the vaccine remains the detail most often cited: he lived on his professor's salary while his sugar cubes reached hundreds of millions of children ^[7][8].

Sabin liked to say that a scientist's obligation ran to humanity rather than to any market. Whatever the final date of polio's disappearance turns out to be, the campaign that made eradication conceivable rests on the weakened viruses he coaxed into existence in a Cincinnati laboratory ^[6][8].